Explore

Endocrinology Meet 2020

3rd Global Diabetes Summit 2020

Helsinki, Finland
15 - 16 July 2020
The conference ended on 16 July 2020

Important Dates

Early Bird Deadline
27th January 2020
Abstract Submission Deadline
8th June 2020
Final Abstract / Full Paper Deadline
15th July 2020

About Endocrinology Meet 2020

ME Conference invite all participants to “3rd Global Diabetes Summit” which is scheduled during, July 15-16, 2020 at Helsinki, Finland which includes prompt keynote presentations, Oral talks, Poster presentations, and Exhibitions.ME Conference series through its open access initiative is committed to making a genuine and reliable offering to the scientific community and to the world. This conference centralized around the theme ”Commitment to Excellence in the field of Diabetes and Endocrinology”

Topics

Pediatric endocrinology, Endocrine neoplasia and cancer, Cardiovascular endocrinology, Endocrinology research and development, Diabetes research, Diabetes and endocrinology, Diabetes mellitus and borderline diabetes/pre cursor, Type 2 diabetes mellitus

Call for Papers

3rd Global Diabetes Summit, will be organized around the theme “Commitment to Excellence in the field of Diabetes and Endocrinology”

Endocrinology Meet 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Endocrinology Meet 2020

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Our conference can review the major event in developing, upgrading and teaching Endocrinology, Diabetes, thyroid, reproduction and Metabolic Syndromes. Our Event strongly initiated by the possibilities offered in the field by cellular endocrinology and by the progress taking place in clinical biochemistry and experimental pharmacology, which can be reviewed by our World Congress. In the same way, the development leading in the field of clinical trials, and large meta-analysis will lead us to understand the possibilities, limits, risks, and advantages of our therapies and diagnostic approaches taking place in the field of diabetes and endocrinology.

Keep Up to Date with PaperCrowd

Sign up and follow your favorite conferences.

We are no longer accepting conference submissions on PaperCrowd. We apologise for any inconvenience.